Market News Today — AI-Curated Stock & Crypto Headlines

Nike is cutting 1,400 more jobs — the company’s shakeup is not done yet

Nike on Thursday said it would cut around 1,400 jobs in its global operations, the latest efforts to shrink staff …

Employee buyouts like Microsoft’s could become more common. Here’s what workers need to know.

In today’s job market, buyouts like what Microsoft is reportedly proposing might become more common.

Mobileye’s robotaxi ambitions have ‘progressed significantly,’ and the stock surges

A key partner also announced expansion plans, which Mobileye said can show off its technology.

Trump is swaying the market like no president has in decades, analysis shows

Data suggest President Trump has been the driver behind the best and worst days for stocks in his second term.

Meta plans to cut 10% of workforce, or 8,000 jobs, as it doubles down on AI

Meta’s latest workforce reduction comes as the company aims to spend up to $135 billion on AI this year

What the Trump administration's move to reclassify marijuana means for investors

The Department of Justice said it will immediately move FDA-approved marijuana from Schedule I to Schedule III under the Controlled …

NYC Mayor Mamdani knocked Ken Griffin in pied-a-terre tax promo. His firm calls the move 'shameful'

Chief Operating Officer Gerald Beeson saying in a memo that targeting Griffin showed "ignorance and disdain" toward contributors to the …

Nike cuts 1,400 roles in second round of layoffs this year

Nike announced 1,400 layoffs, primarily in its technology department, on Thursday after previously cutting 775 jobs in January.

Here’s how much money the 2026 NFL draft picks will make — and who’s at risk of losing millions

Three NFL players will make over $50 million in tonight’s draft

Intel's stock soars 15% as results top estimates, with chipmaker showing signs of growth

Intel has been a Wall Street darling of late even as the business has yet to find much momentum.

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

Regeneron is the latest in a string of major drugmakers to make pricing concessions for new and existing medicines under …

Cheap options suggest a big post-earnings swing next week for these tech titans

Wall Street is underestimating a potential price explosion in next week’s tech-stock earnings reports.